Dr. Janice Dutcher Moves Offices

August 19th, 2011 by Jay Bitkower, ACKC president and survivor

Dr. Janice Dutcher has moved her clinical practice and IL-2 treatment program from the Montefiore Medical Center in the Bronx to the St. Luke’s Roosevelt Hospital Center in Manhattan where  Dr. Dutcher is the Director of the Immunotherapy Program. 

Dr. Dutcher is a board-certified medical oncologist who has dedicated her career to caring for people who are stricken by cancer. She treats patients for renal cell cancer, melanoma, breast cancer and hematologic malignancies She is recognized as one of the foremost expects in renal cell carcinoma and one of the few oncologists who continues to offer IL-2 therapy. For a summary of the latest trial data for IL-2, refer to our summary of the ASCO 2010 Conference presentation on Interleukin-2 by David McDermott of Dana Farber Cancer Institute, see ASCO Trial Results. For an historical perspective on the seminal trial data for IL-2, click here IL-2 Seminal Trials.   

Dr. Dutcher has treated over 500 patients with High-Dose Interleukin-2, the only therapy that has provided a complete, durable response in both RCC and melanoma patients, albeit in a small minority of cases. She has also participated in several trials for targeted therapies. 

Dr. Dutcher is chair of the Renal Cancer Subcommittee of the Genitourinary Committee for the Eastern Cooperative Oncology Group (ECOG), which is an NCI funded research consortium, and she is a founding member of the Cytokine Working Group, which is dedicated to the study of new therapies for kidney cancer and melanoma, and for the development of new approaches to immunotherapy of cancer. 

For the past six years, she has been a member of the American Board of Internal Medicine, Medical Oncology Board examination committee. She is a past chair of the Young Investigator Grants Award committee of the American Society of Clinical Oncology (ASCO). She is a past member of the National Cancer Institute’s committee for review of Cancer Centers and is past Chair of the Food and Drug Administration Oncologic Drug Advisory Committee.  She participated for the past seven years as a faculty member in the ASCO/AACR (American Association for Cancer Research) Workshop in training young investigators in clinical trials methodology. She is currently involved in ASCO’s efforts to develop curriculum for continued education and certification.

Appointments for Patients
212-636-3334

St Luke’s Roosevelt Hospital Center
1000 10th Ave  (West 58th-59th Streets)  Suite 11C02
New York, NY 10019

3 Responses to “Dr. Janice Dutcher Moves Offices”

  1. October 25, 2012 at 7:23 pm, James skwarczynski said:

    Renal cell kidney cancer patient since July 2011. I am getting 4 mg something with fluids weekly and Sutent 50 mg (on my tenth cycle). Rumors have metastasis to liver and lungs. Although disease is stable, I feel like I am treading water. Dr. Logan is my attending physician and my fear is we are not being aggressive enough with our treatment. I have heard of new drugs and clinical trials that I feel we should pursue. The disease is creating hyper calcium and my creatin levels are some what elevated. Dr Logan is playing by the book and I need to find someone who will think outside the box. I know there are many other options we just need to explore them.
    Please help. I can be reached t 317-771-0437

    Reply

    • February 11, 2013 at 3:56 pm, Margie Fultz said:

      Brian Wasson asked about you. He says you have been on his heart and he is praying about you . I commute with him through Corriinks email. I am passing this on for him. Is there an email he can write you at?

      Thanks,
      Margie

      Reply

  2. July 18, 2014 at 10:54 pm, Earnest said:

    I see a lot of interesting posts on your website. You have to spend a lot of time
    writing, i know how to save you a lot of work, there is a tool that creates readable, google friendly articles in couple of minutes, just search in google – k2 unlimited content

    Reply

Leave a Reply